|
SDI Group PLC - Cambridge-based medical technology - Estimates revenue was about £69 million for the financial year that ended on April 30, up from £49.7 million the year before. Adjusted pretax profit is expected to be in the region of £11.8 million, unchanged from financial 2022 and in line with current expectations, it says. Looking ahead, SDI says it continues to invest in its existing businesses and in ‘acquiring complementary businesses’. Expects to continue its buy-and-build strategy in financial 2024. ‘2022 was a busy calendar year for SDI, with four new businesses joining the group, all of whom have contributed to an excellent financial year,’ Chair Ken Ford says. ‘We have executed once again on all facets of our buy and build strategy, delivering a record adjusted operating profit performance’ in financial 2023. Current stock price: 151.40 pence each, down 13% on Thursday morning in London 12-month change: down 7.1% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
